Tunnell’s subject matter experts have written a number of informative pieces. Here are a sampling of articles that have been published in leading industry publications.
VIEW OUR PUBLISHED ARTICLES BELOW
March. 2019 – The principals described may be applied to both commercial and precommercial stages of the product lifecycle.
Feb. 2019 – By taking assessment of Quality Control maturity and making intentional plans for improvement, companies can realize transformative effects in the organization.
Dec. 2018 – Julia O’Neill co-authors article for Journal of Pharmaceutical Innovation.
Dec. 2018 – Data integrity is of paramount importance to ensure patient health and safety and to improve shareholder value.
Nov. 2018 – Maryann Gallivan discusses the elements of an effective organization.
Oct. 2018 – Tunnell’s Kip Wolf addresses the question: How can one prevent or detect malicious intent as it relates to changes to information and the impact to data integrity?
The Central Role For Contract Manufacturers In Developing Control Strategy For Gene Therapy Products
Oct. 2018 – Tunnell’s Julia O’Neill discusses statistics, chemical engineering and the curse of dimensionality.
Jun. 2018 – Tunnell’s Walter Matzmorr discusses the cross functional process of planning for a Pre-Approval Inspection.
Losing Sight of the Intended Purpose of Specifications Has Consequences for the CMO-Sponsor Relationship
Mar. 2018 – Julia O’Neill discusses current practices for specification-setting in the pharmaceutical industry.
Mar. 2018 – Tunnell’s Kip Wolf explains how firms that create and manage electronic documents can improve compliance.
Mar. 2018 – Tunnell Consultants Greg Anthos and Scott Myers explain how a company reduced its 15-day throughput time by 30% within 3 months.